Join us at the Global Congress on Stem Cell, Tissue Science, and Regenerative Medicine, scheduled from April 24-25, 2025, in Paris, France. This pioneering conference brings together leading scientists, researchers, clinicians, and industry experts to explore the latest advancements and applications in stem cell therapy, tissue engineering, and regenerative medicine.
Attendees will have the opportunity to engage in stimulating discussions and gain insights into cutting-edge research through keynote presentations, panel discussions, and poster sessions. The congress aims to foster collaboration among professionals from academia, healthcare sectors, and biotech industries, driving forward the development of transformative therapies and treatments.
Topics of discussion will include stem cell biology, biomaterials and scaffolds, organ regeneration, ethical considerations, clinical trials, and regulatory aspects. Participants can expect to network with peers, exchange ideas, and establish potential collaborations that could shape the future of healthcare.
Mark your calendars now and be part of this influential gathering at the Global Congress on Stem Cell, Tissue Science, and Regenerative Medicine in 2025.
Abstract Submission Deadline: Nov 26, 2024
Early Bird Registration: Nov 29, 2024
Mid Term Registration: Dec 16, 2024
Final/Onsite Registration: Apr 24, 2025
Group Lead, Stem cells and Differentiation, Institut de Biologie Valrose
France
Pro-Vice-Chancellor for Research & Impact and Professor of StemCell Biology, University of Liverpool
United Kingdom
Medical Director of Cleveland Clinic Consortia for Pain
USA
Lung Bioengineering and Regeneration, Lund University
Sweden
Department of Biological Sciences, University of North Carolina at Charlotte
USA
General Director, TiPhage
Turkey
Dear Colleagues,
I’m delighted to welcome you to the Global Congress on Stem Cells, Tissue engineering and Regenerative Medicine 2025 to be held in the iconic European city of Paris, venue of the 2024 Olympic Games. Where better to gather as experts in the development and use of stem cell therapies to discuss the latest developments in science, translation and clinical effectiveness. Stem cell biology is still a young field and sharing our discoveries and insights will be essential if we are to find the best way of using these enigmatic cells for the benefit of patients and health providers around the world.
Whether you are a scientist, clinician, or industrial expert, we look forward to seeing you in Paris this spring.
Professor Anthony Hollander
Pro-Vice-Chancellor for Research and Impact and Professor of Stem Cell Biology
University of Liverpool, UK
and
Founder, Director, and Chief Scientific Officer
TrophiCell Ltd